| 1 |
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies
Katherine E. Wright, Kathryn A. Hjerrild, Jonathan D. Bartlett et al. · Nature
Open access |
15 Aug 2014 |
243 |
| 2 |
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Susan Thrane, Christoph Mikkel Janitzek, Sungwa Matondo et al. · Journal of Nanobiotechnology
Open access |
18 Apr 2016 |
215 |
| 3 |
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies
Daniel G. W. Alanine et al. · Cell
Open access |
Jun 2019 |
176 |
| 4 |
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M. Minassian et al. · Med
Open access |
20 Apr 2021 |
170 |
| 5 |
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria
Benjamin G. Mordmüller et al. · Clinical Infectious Diseases
Open access |
3 Jan 2019 |
161 |
| 6 |
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Cyrielle E. Fougeroux et al. · Nature Communications
Open access |
12 Jan 2021 |
131 |
| 7 |
Virus-like particle display of HER2 induces potent anti-cancer responses
Arianna Palladini, Susan Thrane, Christoph Mikkel Janitzek et al. · OncoImmunology
Open access |
29 Nov 2017 |
127 |
| 8 |
Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex
Wilson Wong et al. · Nature
|
11 Dec 2018 |
116 |
| 9 |
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Ruth Payne et al. · JCI Insight
Open access |
14 Jun 2017 |
103 |
| 10 |
Perspectives in allergen immunotherapy: 2017 and beyond
Oliver Pfaar et al. · Allergy
Open access |
24 Nov 2017 |
97 |
| 11 |
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
Jing Jin et al. · npj Vaccines
Open access |
26 Jun 2018 |
84 |
| 12 |
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells
Ieva Bagdonaite, Andrew J. Thompson, Xiaoning Wang et al. · Viruses
Open access |
25 Mar 2021 |
80 |
| 13 |
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system
Kathryn A. Hjerrild, Jing Jin, Katherine E. Wright et al. · Scientific Reports
Open access |
26 Jul 2016 |
76 |
| 14 |
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein
Sara R. Bang-Christensen et al. · Cells
Open access |
28 Aug 2019 |
69 |
| 15 |
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’
Jing Jin, Kathryn A. Hjerrild, Sarah E. Silk et al. · International Journal for Parasitology
Open access |
30 Jan 2017 |
68 |
| 16 |
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
F. Lennartz, Florian Brod, Rebecca A. Dabbs et al. · Nature Communications
Open access |
14 Sep 2018 |
67 |
| 17 |
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
Julie Healer, Wilson Wong, Jennifer K. Thompson et al. · Cellular Microbiology
Open access |
9 Apr 2019 |
57 |
| 18 |
The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine
Morten Agertoug Nielsen et al. · PLoS ONE
Open access |
Sep 2015 |
48 |
| 19 |
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
Merel J Smit et al. · The Lancet Microbe
Open access |
18 Jan 2023 |
44 |
| 20 |
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants
Linda van Oosten et al. · mBio
Open access |
12 Oct 2021 |
44 |
| 21 |
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain
Rafael Bayarri‐Olmos, Manja Idorn, Anne Rosbjerg et al. · The Journal of Immunology
Open access |
23 Jul 2021 |
41 |
| 22 |
Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence
Sunita Gulati, Andreas Holm Mattsson, Sophie Schussek et al. · mBio
Open access |
31 Oct 2023 |
24 |
| 23 |
DNA based neoepitope vaccination induces tumor control in syngeneic mouse models
Nadia Viborg, Michail Angelos Pavlidis, Marina Barrio-Calvo et al. · npj Vaccines
Open access |
27 May 2023 |
24 |
| 24 |
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
Louise Goksøyr, Magdalena Skrzypczak, Maureen L. Sampson et al. · Vaccines
Open access |
20 Dec 2022 |
21 |
| 25 |
Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae
Komi Gbédandé, Nadine Fiévet, Firmine Viwami et al. · Vaccine
|
17 May 2017 |
17 |
| 26 |
Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
Marina Barrio-Calvo, Søren Vester Kofoed, Sofie Cens Holste et al. · Frontiers in Immunology
Open access |
29 Aug 2023 |
14 |
| 27 |
FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells
Jesse A. Coker, Vittorio L. Katis, M. Fairhead et al. · Frontiers in Bioengineering and Biotechnology
Open access |
5 May 2022 |
11 |
| 28 |
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
Sofie Kirial Mørk et al. · Frontiers in Immunology
Open access |
14 Mar 2023 |
10 |
| 29 |
Comparison of functional assays used in the clinical development of a placental malaria vaccine
Caroline Pehrson, Kristine K. Heno, Yvonne Adams et al. · Vaccine
Open access |
22 Dec 2016 |
10 |
| 30 |
Personalized Neoantigen DNA Cancer Vaccines: Current Status and Future Perspectives
Nadia Viborg, Daniela Kleine‐Kohlbrecher, Birgitte Rønø · Journal of Cellular Immunology
Open access |
30 Mar 2024 |
9 |
| 31 |
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Jannick C. Prentoe, Christoph Mikkel Janitzek, Rodrigo Velázquez‐Moctezuma et al. · npj Vaccines
Open access |
15 Nov 2022 |
8 |
| 32 |
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
Francesca Ruzzi, Arianna Palladini, Stine B. Clemmensen et al. · Biomedicines
Open access |
20 Oct 2022 |
8 |
| 33 |
Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails
Emma Probst Brandum, Astrid Sissel Jørgensen, Marina Barrio-Calvo et al. · International Journal of Molecular Sciences
Open access |
26 Jan 2022 |
8 |
| 34 |
Development of a Drosophila S2 insect-cell based placental malaria vaccine production process
Wian A de Jongh, Mafalda Resende, Carsten Leisted et al. · BMC Proceedings
Open access |
Dec 2013 |
7 |
| 35 |
Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines
Christian Garde, Michail Angelos Pavlidis, Pablo Garcés Velástegui et al. · npj Vaccines
Open access |
20 Mar 2025 |
6 |
| 36 |
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Melanie R. Walker, Alexander P. Underwood, Kasper Haldrup Björnsson et al. · Communications Biology
Open access |
Oct 2024 |
6 |
| 37 |
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes
Asolina Braun et al. · Nature Communications
Open access |
30 Aug 2024 |
6 |
| 38 |
SARS-CoV-2 RBD-Specific Antibodies Induced Early in the Pandemic by Natural Infection and Vaccination Display Cross-Variant Binding and Inhibition
Melanie R. Walker, Daria N. Podlekareva, Stine Johnsen et al. · Viruses
Open access |
24 Aug 2022 |
6 |
| 39 |
Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer
Arunima Mukhopadhyay, Charlotte Dyring, David Ian Stott · Vaccine
Open access |
11 Nov 2013 |
6 |
| 40 |
Capsid-like particles decorated with the SARS2-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Cyrielle Fougeoux et al. · Research Square
PreprintOpen access |
28 Jul 2020 |
5 |
| 41 |
Development of Pregnancy-Associated Malaria Vaccine Using the ExpreS2 Insect Cell Expression System
Charlotte Dyring · BioProcessing Journal
|
19 Oct 2012 |
5 |
| 42 |
Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine
Søren Vester Kofoed, Marina Barrio-Calvo, Michail Angelos Pavlidis et al. · Cancer Immunology Immunotherapy
Open access |
24 Jul 2025 |
3 |
| 43 |
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
Justin Doritchamou et al. · Lab Animal
Open access |
6 Nov 2023 |
3 |
| 44 |
Vaccine monitoring shows that focused immunization with SARS-CoV-2 receptor-binding domain provides a better neutralizing antibody response than full-length spike protein
Rafael Bayarri‐Olmos, Manja Idorn, Anne Rosbjerg et al. · Research Square
PreprintOpen access |
4 Jan 2021 |
3 |
| 45 |
Chemokine Receptor N-Terminus Charge Dictates Reliance on Post-Translational Modifications for Effective Ligand Capture and Following Boosting by Defense Peptides
Ting Xu, Anne Sophie Schou, Jarkko J. Lackman et al. · International Journal of Molecular Sciences
Open access |
9 Oct 2024 |
2 |
| 46 |
Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens via TLR4/2-dependent mechanisms
Sruthi Vijaya Retnakumar, Suraj Chandrabhan Singh, Srinivasa Reddy Bonam et al. · Frontiers in Immunology
Open access |
4 Mar 2026 |
1 |
| 47 |
Validation of novel conditional ligands and large-scale detection of antigen-specific T cells for H-2Dd and H-2Kd
Trine Sundebo Meldgaard, Nadia Viborg, Sara Suarez Hernandez et al. · Scientific Reports
Open access |
29 May 2024 |
1 |
| 48 |
mRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens
Mark von Bülow Møiniche, Kristoffer Haurum Johansen, Jorge Parrón‐Ballesteros et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
29 Feb 2024 |
1 |
| 49 |
Characterization of SARS‐CoV‐2 humoral immune response in a subject with unique sampling: A case report
Melanie R. Walker, Manja Idorn, Anja Bennett et al. · Immunity Inflammation and Disease
Open access |
Jun 2023 |
1 |
| 50 |
Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface
Tobias Jakobsson, Pär Comstedt, Sven Bergström et al. · Pathogens
Open access |
8 Nov 2024 |
0 |